Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules

Atherosclerosis-predominant vasculopathy is a common complication of diabetes with high morbidity and high mortality, which is ruining the patient's daily life. As is known to all, traditional Chinese medicine (TCM) SHENQI compound and western medicine rosiglitazone play an important role in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Hong, Duan, Yuhong, Fu, Xiaoxu, Xie, Hongyan, Liu, Ya, Yuan, Haipo, Zhou, Mingyang, Xie, Chunguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283585/
https://www.ncbi.nlm.nih.gov/pubmed/30521536
http://dx.doi.org/10.1371/journal.pone.0207683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283585/
https://www.ncbi.nlm.nih.gov/pubmed/30521536
http://dx.doi.org/10.1371/journal.pone.0207683

Ejemplares similares